DISPROPORTIONALITY ANALYSIS FOR PHARMACOVIGILANCE OF MEDICAL DEVICE RELATED ADVERSE EVENTS REPORTED TO THE FDA

被引：0
|
作者：
Duggirala, H. J. [1 ]
Herz, N. D. [1 ]
Canos, D. A. [1 ]
Sullivan, R. [1 ]
Schaaf, Richard [1 ]
Pinnow, E. [1 ]
Marinac-Dabic, D. [1 ]
机构：
[1] Ctr Devices & Radiol Hlth Food & Drug Adm, Silver Spring, MD 20993 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2011年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [31] Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database A Disproportionality Analysis
    Shamloo, Behrooz K.
    Chhabra, Pankdeep
    Freedman, Andrew N.
    Potosky, Arnold
    Malin, Jennifer
    Smith, Sheila Weiss
    DRUG SAFETY, 2012, 35 (06) : 507 - 518
  • [32] Signal Detection of Adverse Medical Device Events in the FDA/MAUDE Database
    Olaleye, David O.
    Olaleye, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S142 - S143
  • [33] Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system
    Li, Zhiping
    Zou, Wenbin
    Yuan, Jiao
    Zhong, Yunxiang
    Fu, Zhiwen
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (06) : 763 - 770
  • [34] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [35] Antibiotics-Induced Liver Injury: A Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events
    Mendes, D.
    Dias, P.
    Alves, C.
    Batel-Marques, F.
    DRUG SAFETY, 2015, 38 (10) : 1006 - 1006
  • [36] PAIN AND ARTHRALGIA ADVERSE EVENTS ASSOCIATED WITH CRIZANLIZUMAB AND VOXELOTOR: DISPROPORTIONALITY ANALYSIS OF US FDA ADVERSE EVENTS REPORTING SYSTEM (FAERS)
    Ologunowa, A.
    Caffrey, A. R.
    VALUE IN HEALTH, 2023, 26 (06) : S208 - S208
  • [37] Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events
    Mendes, D.
    Alves, C.
    Batel-Marques, F.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (03) : 307 - 313
  • [38] Analysis of Reported Adverse Events Related to Hemospray
    Ahmed, Khalid
    Abdallah, Mohamed
    Abbas, Daniyal
    Jaber, Fouad
    Abdalla, Abubaker O.
    Mohamed, Mouhand
    Mcdonald, Nicholas
    Hanson, Brian J.
    Bilal, Mohammad
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (04) : 402 - 406
  • [39] Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System
    Duggirala, Hesha J.
    Herz, Naomi D.
    Canos, Daniel Arthur
    Sullivan, Roberta A.
    Schaaf, Richard
    Pinnow, Ellen
    Marinac-Dabic, Danica
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 87 - 93
  • [40] A Real-World Pharmacovigilance Analysis of Cardiac Adverse Events Associated with Newer Antibody-Drug Conjugates: A Disproportionality Analysis from FDA Adverse Event Reporting System Database
    Dilip, Deepika
    Sharma, Pritika
    Pawa, Arpita
    Wu, Ben
    Veasaw, Kassidy
    Drugge, Elizabeth
    Steinberg, Amir
    BLOOD, 2024, 144 : 7800 - 7801
12345